These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16929364)

  • 1. Thyroid-hormone therapy and thyroid cancer: a reassessment.
    Biondi B; Filetti S; Schlumberger M
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):32-40. PubMed ID: 16929364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormonal therapy in differentiated carcinoma of the thyroid gland].
    Francia G; Davì MV; Petroziello A; Sussi PL
    Chir Ital; 1994; 46(4):56-8. PubMed ID: 7882445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with L-thyroxine for differentiated thyroid carcinoma].
    Łacka K
    Wiad Lek; 2001; 54 Suppl 1():368-72. PubMed ID: 12182051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive determination of TSH in the follow-up of TSH-suppressive therapy of patients with differentiated thyroid cancer.
    Mann K; Saller B; Mehl U; Hörmann R; Moser E
    Nuklearmedizin; 1988 Feb; 27(1):24-8. PubMed ID: 3368333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapy.
    Taillard V; Sardinoux M; Oudot C; Fesler P; Rugale C; Raingeard I; Renard E; Ribstein J; du Cailar G
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):709-14. PubMed ID: 21645022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.
    Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bax JJ; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):284-91. PubMed ID: 16487438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of thyroid hormone on the growth of thyroid cancer].
    Shiba E; Miyauchi K; Kobayashi T; Takai S; Mori T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3678-84. PubMed ID: 2688557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
    Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
    Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of thyrotropin-suppressive therapy in patients with well-differentiated thyroid carcinoma].
    Miyakawa M
    Nihon Rinsho; 2007 Nov; 65(11):2073-7. PubMed ID: 18018573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
    Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
    Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial.
    Sugitani I; Fujimoto Y
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4576-83. PubMed ID: 20660039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
    Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
    Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Principles of thyroid hormone treatment (author's transl)].
    Pfannenstiel P
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):961-6. PubMed ID: 6775193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
    Papi G; Pearce EN; Braverman LE; Betterle C; Roti E
    Am J Med; 2005 Apr; 118(4):349-61. PubMed ID: 15808130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormonal replacement therapy in women after surgery for thyroid cancer treated with suppressive doses of L-thyroxine].
    Jastrzebska H; Gietka-Czernel M; Zgliczyński S
    Wiad Lek; 2001; 54 Suppl 1():383-8. PubMed ID: 12182054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
    Biondi B; Cooper DS
    Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
    Do Cao C; Wémeau JL
    Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S47-52. PubMed ID: 26826483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term overt hypothyroidism induces discrete diastolic dysfunction in patients treated for differentiated thyroid carcinoma.
    Hoftijzer HC; Bax JJ; Heemstra KA; Bleeker GB; Delgado V; van der Klaauw AA; Romijn JA; Smit JW; Corssmit EP
    Eur J Clin Invest; 2009 Mar; 39(3):204-10. PubMed ID: 19260950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of rh-TSH and thyroid hormone withdrawal in patients with differentiated thyroid cancer: preliminary evidence for an influence of age on the subjective well-being in hypothyroidism.
    Heinzel A; Kley K; Mueller HW; Hautzel H
    Horm Metab Res; 2012 Jan; 44(1):54-9. PubMed ID: 22109678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.